The association of CTHRC1 with tumor progression is demonstrated in various cancers, including melanoma, hepatocellular carcinoma, lung cancer, gastric cancer, pancreatic cancer, breast cancer, and colorectal cancer [15–17]. This evidence concerns the gene CTHRC1 and familial pancreatic carcinoma.